Introduction
The triazole ring is a frequent partner in polycyclic heterocyclic systems of biological significance and industrial applications. Compounds containing a fused 1,2,4-triazole moiety have attracted attention in the past few years owing to their biological activity. A number of these class of compounds act as antibacterial [1] [2] [3] , antifungal [4] [5] [6] , anti-inflammatory [7] , analgesic [8] [9] [10] , antituberculosis [11] and anticonvulsant agents [12] [13] [14] . In addition, a large number of triazole derivatives have antiulcer [15, 16] , antidepressant [17, 18] , insecticidal [19] , hypolipidemic [20] , antidiabetic [21] and antimitotic activity [22] .
Also, azetidin-2-ones of 3-pyridyl-4-amino-5-mercapto-1,2,4-triazoles [23] and 4-(N-pyridylcarboxamido)-5-mercapto-3-substitued 1,2,4-triazoles [24] have been reported to possess significant activity as antitumor and antiviral agents. On the other hand, quinoline derivatives have been proven as privileged core structures and confirmed in bioactive natural products and in various pharmaceutical agents. They are known for their antiplasmodial properties and have been used as the staring compounds for new antimalarial agents [25, 26] .
Prompted by the varied biological activities of triazole derivatives and in continuation of our efforts for the synthesis of biologically active heterocycles [27] [28] [29] , the present work describes the synthesis of novel 1,2,4-triazole derivatives attached with quinoline moiety with the aim of enhancement of their biological activity.
Experimental

Instrumentation
Melting point of the synthesized compounds was determined in Perkin Elmer apparatus and is uncorrected. IR spectra were recorded using KBr pellets. 1 H NMR spectra were recorded on Mercury-300BB (NMR 200) in CDCl3, DMSO-d6 as solvent. Tetramethylsilan (TMS) served as an internal reference and chemical shifts were expressed in δ (ppm). Mass spectra were recorded on GC-MS Shimadzu QP2010. All the microanalysis and antimicrobial activities were performed by the Micro analytical unit, Cairo University.
Synthesis
2-(Quinolin-8-yloxy)acetohydrazide (1)
The titled compound was prepared according to the method described in the literature [30] . A mixture of hydrazine hydrate (0.01 mol) and ethyl 2-(quinolin-8-yl-oxy)acetate (0.01 mol) in ethanol (30 mL) was heated under reflux for 4 hours. After cooling, the precipitated solid was collected and recrystallized from ethanol. 
4-Amino-5-[(quinolin-8-yloxy)methyl]-4H-1,2,4-triazole-3-thiol (2)
Carbon disulfide (0.015 mol) was added drop wise to a solution of hydrazide 1 (0.01 mol) in ethanol (30 mL) and potassium hydroxide (0.015 mol). The mixture was stirred at room temperature for 14 h., dry diethyl ether (20 mL) was added and the separated solid was filtered off and washed with diethyl ether, the potassium salt was used for the next stage without further purification.
Scheme 1
Hydrazine hydrate (0.02 mol) was gradually added to the above potassium salt (0.01 mol) dissolved in water (20 mL) and all were refluxed with stirring for 4h. The reaction mixture was cooled and acidified with conc. HCl. A yellow solid separated out which was filtered, washed with water and purified by recrystallization from ethanol to afford triazole 2 (Scheme 1 
General procedure for preparation of 3a-b
A mixture of triazole 2 (0.01 mol) and urea/thiourea (0.015 mol) was fused at 232 o C for 2h. After cooling, the solid was triturated with water and filtered off, washed and crystallized from ethanol.
Alternative method for synthesis of 3b: A mixture of an equimolar amount of compound 2 and CS2 (0.02 mol) in DMF (50 mL) was refluxed for 6 h. then it cooled and poured onto ice. The product was filtered off and crystallized from acetic acid (Scheme 1).
3-((Quinolin-8-yloxy)methyl)- [1, 2, 4] triazolo [3,4- 
General procedure for preparation of 5a-c
A mixture of triazole 2 (0.01 mol) and aromatic acids namely (p-nitrobenzoic acid, p-aminobenzoic acid, p-hydroxy benzoic acid) (0.01 mol) in the presence of POCl3 (15 mL) was refluxed for 3 h. After removal of the excess of POCl3 under reduced pressure, the residue was added to crushed ice and stirred at room temperature for 1 h. during this time the solution was gradually neutralized with Na2CO3, the solid product was filtered off, washed with water, dried and crystallized from DMF (Scheme 1). [1, 2, 4] triazolo [3,4- 
8-((6-(4-Nitrophenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole-3-yl)methoxy)quinoline
4-(3-((Quinolin-8-yloxy)methyl)-
General procedure for preparation of 6a,b
Triazole 2 (0.01 mol) was fused with phthalic anhydrid or maleic anhydride (0.01 mol) for 3h., the reaction mixture was cooled, triturated with water, the separated solid was filtered, washed with water and crystallized from ethanol (Scheme 2). 
2-(3-Mercapto-5-((quinolin-8-yloxy)methyl)-4H-1,2,4-triazol-4-yl)isoindoline-1,3-dione
3-((Quinolin-8-yloxy)methyl)-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-6-(7H)-one (10)
To a solution of triazole (0.01 mol) in acetic acid (50 mL), chloroacetic acid (0.01 mol) and fused sodium acetate (0.01 mol) were added. The reaction mixture was refluxed for 6h, the separated solid was filtered and recrystallized from ethanol 
General procedure for preparation of 11a-c
To a mixture of triazole 2 (0.01 mol) and different amino acids namely (anthranilic acid, glycine, and valine) (0.01 mol), POCl3 was added and the content was heated under reflux for 2h on an oil bath. Excess of POCl3 was then removed and the residue was poured onto crushed ice and stirred well. These were then washed with NaHCO3 (5%) and the resulting solids were then, filtered, washed with water and crystallized from DMF (Scheme 3). N-methyl-3-((quinolin-8-yloxy)methyl)-[1,2,4]  triazolo[3,4-b][1,3,4]thiadiazol-6-amine (12) An equimolar amount of triazole 2 and methyl isothiocyanate (0.01mol) in DMF (30 mL) was refluxed for 4h, cooled, and then poured onto ice. The product solid was filtered off and crystallized from ethanol (Scheme 3 
2-Methyl-1-[3-(quinolin-8-yloxymethyl)-[1,2,4]triazolo[3,4-b] [1,3,4]thiadiazol-6-yl]-propylamine
N-(3-Mercapto-5-((quinolin-8-yloxy)methyl)-4H-1,2,4-triazol-4-yl) formamide (13)
Triazole 2 (0.01 mol) in formic acid (10 mL 
Antimicrobial activity test
The tested microorganisms were Gram-positive bacteria (Staphylococcus aureus) and Gram-negative bacteria (Escherichia coli). In addition, some fungi (Candida albicans and Aspergillus flavus) were also tested. On the other hand, Tetracycline and Amphotericin B were used as standard antibacterial and antifungal agents, respectively. The observed data on the antimicrobial activity of the compounds and the standard drugs are given in Table 1 .
Agar diffusion method was used for the determination of the preliminary antibacterial and antifungal activity [31] and the results were recorded for each tested compound as the average diameter of inhibition zones (r) of bacterial or fungal growth around the disks in millimeters at 100 μg concentrations in dimethylsulfoxide.
The Gr(+) test organism and Gr(-) test organism were applied using 8 pore suspension of each test organism separately spreaded over a petri dish containing a solid nutrient agar medium of the following composition (g/L).
Beef extract, 3.0; tryptone, 5.0; Agar, 15.0; and distilled water, 1000.0. After immediately fresh inoculation of the tested organism, a well per each Petri dish was made, and the 0.1 g of the tested compound was filled the 6 mm in diameter well respectively then incubated at 37 o C for 48 h, the diameter of the inhibition zone was measured in mm. Also the antifungal activities were tested using spore suspension of each tested organism separately, spreaded over Petri dish containing solid Czapeks Dox agar of the following composition (g/L).
Sucrose, 30.0; MgSO4, 0.5; KCl, 0.5; FeSO4, 0.01; NaNO3 3.0; K2HPO4 1.0; Agar, 20.0; and distilled water, 1000.0. After immediately fresh inoculation of the test organism, a 6 mm well per each Petri dish was made, and the tested compounds were added to fill wells respectively, and then incubated at 28 °C for 7 days.
Results and discussion
Synthesis
Scheme 1-3 show the synthetic pathways to prepare the target compounds 2-14. The starting material 4-amino-5-[(quinolin-8-yloxy) methyl]-4H-1,2,4-triazole-3-thiole (2) was synthesized from the reaction of acid hydrazide 1 [30] with carbon disulfide in ethanol containing potassium hydroxide followed by treatment with hydrazine hydrate. The structure of triazole 2 was elucidated by 1 H NMR spectrum that showed signals at δ 13.9 and 10.5 ppm corresponding to NH2 and SH protons respectively. Also, IR spectrum displays absorption bands at 3263-3145 and 2668 cm -1 due to NH2 and SH absorption (Scheme 1).
Triazole 2 with the reactive amino and thio groups proved to be versatile key precursor for constructing wide range of fused triazole derivatives. Thus, the reactivity of triazole 2 towards variety of chemical reagents with the aim of synthesis of fused heterocyclic systems of expected biological activity was investigated. The reaction of compound 2 with urea or thiourea afforded [1, 2, 4 ]-triazolo- [3,4-b] [1, 3, 4] -thiadiazoles 3a and 3b respectively. Compound 3b was prepared also from the reaction of 1,2,4-triazole 2 with carbon disulfide in DMF. The structures of the products were assigned on the basis of their spectral data and elemental analysis. Treatment of triazole 2 with acetyl chloride in dry pyridine afforded product 4. On the other hand, reaction of triazole 2 with aromatic acids namely (p-nitrobenzoic acid, p-aminobenzoic acid and p-hydroxy benzoic acid in the presence of POCl3 gave 5a-c respectively (Scheme 1).
Furthermore, heating of triazole 2 with acid anhydride namely phthalic anhydride or maleic anhydride afforded triazole derivatives 6a and 6b respectively where as refluxing of triazole 2 in acetic anhydride due to ring closure to afford 8-((6-methyl- [1, 2, 4] triazolo [3,4-b] [1,3,4]thiadiazole 7. However, triazole derivative 8 can be synthesized from reaction of triazole 2 with p-hydroxybenzaldhyde in the glacial acetic acid. Treatment of triazole 2 with sodium nitrite gave product 9 (Scheme 2).
Furthermore, the reaction of triazole 2 with chloroacetic acid in the presence of sodium acetate furnished triazolo [3,4-b] [1, 3, 4] thiadiazin derivative 10.
The reactivity of triazole 2 towards amino acids to give triazolo [3,4-b] [1, 3, 4] thiadiazole derivatives was investigated. Thus, the reaction of triazole 2 with valine, glycine and anthranilic acid in the presence of POCl3 due to formation of triazoles 11a-c, respectively (Scheme 3). The structures of the products were confirmed on the basis of their spectral data. Candida albicans  3a  ----3b  21  20  -12  4  14  12  -12  5a  ---11  5b  12  11  --5c  13  11  -12  6a  17  17  12  12  6b  21  20  11  12  7  ----8  14  14  -13  9  14  12  --10  14  12  --11a  15  13  --11b  13  10  --11c  15  11  --12  15  13  -13  Tetracycline  24 Reaction of compound 2 with methyl isothiocyanate in the presence of DMF gave heterocycle 12. On the other hand, heating of triazole 2 with formic acid afforded triazole 13. When triazole 2 was allowed to react with 1,3-dicarbonyl compounds like ethylacetoacetate, triazole 14 was formed (Scheme 3).
Antimicrobial activity
1,2,4-Triazole derivatives were reported to have biological activity. In this study, some of the synthesized compounds containing 1,2,4-triazole moiety appear to be promising as potential bio responses which increase their importance towards application in pharmacological, industrial and agriculture fields. Therefore, their effectiveness against a number of microorganisms was tested ( Table 1) .
The results revealed that majority of the synthesized compounds showed varying degrees of inhibition against the tested microorganisms. In general, the inhibitory activity against the Gram-positive bacteria and Gram-negative bacteria was higher than that of the tested fungi. The tested compounds showed moderate (6a, 11 and 12) to high (3b and 6b) inhibitory effect towards tested bacteria ( Table 1) . Introduction of thiadiazolethione and pyrrolidindione moiety to triazole ring to give mixed heterocyclic systems 3b and 6b enhance antibacterial activities when compared with Tetracycline. It has been observed through the results in Table 1 that 6a and 6b derivatives showed both antifungal and antibacterial activities towards the tested organisms. On the other hand, triazoles 8 and 12 showed moderate activity towards the most tested microorganisms, while it is inactive towards Aspergillus flavus. In summary, the presence of thiadiazole moiety attached to fused triazole system enhances the inhibition zones of the tested microorganisms.
Conclusion
In the present paper, we have described the synthesis of 1,2,4-triazole derivatives fused to five and six membered rings from 4-amino-5-[(quinolin-8-yloxy)methyl]-4H-1,2,4-triazole-3-thiole (2). It was observed that some of the synthesized compounds behave as efficient antibacterial and antifungal agents when compared with standard drugs. The structure of all derivatives was confirmed and characterized by elemental analysis and spectroscopic studies.
